Notwithstanding the medium-term gains, the acquisition of JB Chemicals & Pharmaceuticals brings uncertainty over successful ...

KKR sold off its 46.39% stake in J.B. Chemicals and Pharmaceuticals to Torrent Pharma after grooming the Indian drugmaker ...

The deal grants Torrent Pharma access to a thriving pharmaceutical business. JB Pharma makes drugs for gastroenterology, ...

Prabhudas Lilladher recommended accumulate rating on Torrent Pharmaceuticals with a target price of Rs 3850 in its research ...

Torrent said on Sunday that it would acquire a controlling stake in JB Pharma from global investment firm KKR, at an equity ...

Torrent Pharmaceuticals Ltd. received a share price target upgrade from BofA Securities, on the likely synergies in operating ...

Torrent has signed definitive agreements to acquire stake in JB Pharma at an equity valuation of Rs256.89bn ($3bn) on a fully ...

Torrent Pharmaceuticals to acquire 46.39% stake in JB Chemicals and Pharmaceuticals, merging to strengthen global presence.

According to Nuvama Institutional Equities, TRP will initially acquire a 46.39 per cent stake in JBCP from private equity ...

Torrent Pharmaceuticals has announced the acquisition of a controlling stake in JB Pharma from global investment firm KKR at ...

ICICI Securities recommended hold rating on Torrent Pharma with a target price of Rs 3500 in its research report dated July ...

India's Torrent Pharmaceuticals said on Sunday it will acquire a 46.39% controlling stake in smaller peer JB Chemicals and Pharmaceuticals from New York-based investment firm KKR , and plans to merge ...